Arteriosclerosis Clinical Trial
Official title:
Intravascular Narrow Field Magnetic Resonance Arterial Wall Imaging
This study will compare four methods of imaging arteries:
- angiography (x-ray picture)
- intravascular ultrasound (ultrasound from inside the artery)
- magnetic resonance imaging (MRI) from outside the body
- MRI using an antenna to take pictures inside the arteries of the pelvis
Standard angiography shows blockages inside the artery, but does not provide any information
about the arterial wall itself. New ways of looking at the artery walls with MRI and
ultrasound may provide insight into how arteries cause disease.
Patients 21 years of age and older who require catheterization and angiography of the heart,
kidney, or leg arteries because of atherosclerosis (narrowing of the arteries), may be
eligible for this study. Participants will undergo MRI and intravascular ultrasound of the
arteries immediately after their catheterization and angiography. The additional imaging
will add from 1 to 2 hours to the angiogram procedure.
- Angiography: Using the sheaths already in place in the groin artery, catheters
(flexible plastic tubes) are placed inside the arteries in order to inject a contrast
dye to take x-ray pictures. (Patients who had an angiogram of the leg artery as part of
their medical care will not repeat this test.)
- Intravascular ultrasound: An anti-clotting drug called heparin is given through a vein
to prevent clot formation. Blood samples are taken during the test to see if more
heparin is needed. Special wires are used to guide the catheters to the proper location
inside the arteries. A special ultrasound catheter is advanced over one of these wires
to the large artery that supplies blood to the legs. X-rays are used to help the
physician place the ultrasound in the correct location to take ultrasound pictures of
the artery wall.
- Magnetic resonance imaging: A special MRI catheter is advanced through the catheter in
the groin. With the catheter in place, the patient is carried to a stretcher and moved
into a long metal cylinder (the MRI scanner) for imaging. During the scanning, a
contrast drug called gadolinium is injected into an arm vein to brighten the images.
The patient is able to speak through a microphone at all times to the person taking the
pictures.
Coronary artery disease remains the leading cause of death in the United States. Disruption
of atherosclerotic plaque is associated with acute coronary syndromes including myocardial
infarction, but culprit lesions are difficult to identify beforehand. Animal models of
atherosclerosis have proven limited. In vivo plaque characterization might be useful both in
plaque prognostication and in understanding human vascular biology. One imaging modality,
high-resolution magnetic resonance imaging (MRI), has been shown feasible for plaque
visualization and characterization, but still has important limitations. In this pilot study
we hope to apply a new MRI modality using coils (antennae) that are inside the artery being
studied, to achieve superior imaging.
This pilot study will examine whether intravascular arterial wall MRI can visualize the
arterial wall with a higher spatial resolution than currently available techniques of
intravascular ultrasound or conventional magnetic resonance imaging using surface receiver
coils. In particular, we hope to image in high resolution, for the first time, the outer
arterial wall (adventitia), which is not readily visualized. MRI using intravascular coils
may also enable the study of blood flow and contrast accumulation within arterial walls,
potentially key markers of plaque angiogenesis and vulnerability.
;
Endpoint Classification: Safety Study, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Not yet recruiting |
NCT02866656 -
The Clinical Research of Low Intensity Continuous Ultrasonic on Lower Limb Arteriosclerosis Occlusion(ASO) Syndrome
|
N/A | |
Completed |
NCT02510547 -
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
|
Phase 4 | |
Completed |
NCT02264717 -
Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease
|
N/A | |
Completed |
NCT01334268 -
RESOLUTE China RCT
|
N/A | |
Active, not recruiting |
NCT00154180 -
Kronos Early Estrogen Prevention Study (KEEPS)
|
Phase 4 | |
Recruiting |
NCT04343209 -
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)
|
||
Not yet recruiting |
NCT06039748 -
Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study
|
||
Recruiting |
NCT04142021 -
Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coronary CTA and FFRCT in Patients With Complex Coronary Artery Disease (FASTTRACK CABG)
|
||
Recruiting |
NCT06008756 -
MK-0616 (Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
|
Phase 3 | |
Completed |
NCT03253692 -
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
|
||
Active, not recruiting |
NCT04624854 -
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
|
Phase 4 | |
Active, not recruiting |
NCT02921230 -
Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery
|
N/A | |
Recruiting |
NCT01774058 -
The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation
|
Phase 2 | |
Terminated |
NCT01462721 -
The eSVS® Mesh Randomized Post-Market Study
|
N/A | |
Completed |
NCT01221610 -
BIOLUX P-I First in Man Study
|
N/A | |
Completed |
NCT01455974 -
The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients
|
N/A | |
Active, not recruiting |
NCT00863967 -
Early Detection of Arteriosclerosis
|
N/A | |
Active, not recruiting |
NCT00174902 -
The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress
|
Phase 1/Phase 2 | |
Completed |
NCT00050817 -
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
|
Phase 3 |